Skip to content

EV / EBITDA at other companies

USANA Health Sciences logo
USANA Health SciencesUSNA
3.7×-2.0×
NuSkin Enterprises logo
NuSkin EnterprisesNUS
3.5×
Herbalife logo
HerbalifeHLF
5.3×0.0×
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
8.5×+4.1×
FitLife Brands, Inc. logo
FitLife Brands, Inc.FTLF
18.2×+6.2×
The Beauty Health Company logo
The Beauty Health CompanySKIN
3.8×

Other financials

Income statement

See full
Revenue$43.7M-25.2%
Gross profit$34.5M-27.0%
Operating income$1.7M-58.6%
Net income$1.4M-60.7%
EPS (diluted)$0.11-57.7%

Balance sheet

See full
Cash & equivalents$12.5M-44.4%
Total debt$10.2M-17.4%
Total equity$33.3M-2.0%
Total assets$62.1M-19.6%

Cash flow

See full
Operating cash flow$5.0M+124%
CapEx$1.0M+205%
Free cash flow$4.0M+110%

Valuation

See full
Market cap$78.72M-51.3%
Enterprise value$76.45M-50.0%
P/E13.7×-2.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin78.1%-2.2pp
Operating margin3.4%-2.5pp
Net margin2.9%-1.2pp
FCF margin3.8%+1.1pp

Returns & leverage

See full
Return on equity17.1%-13.0pp
Debt / equity0.3×-0.1×
Current ratio+0.3×

Where this comes from

Calculated from Lifevantage Corporation’s reported figures.

Based on the most recent quarter.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifevantage Corporation's EV / EBITDA?
Lifevantage Corporation (LFVN) reported EV / EBITDA of 5.6× in Q1 2026.
How has Lifevantage Corporation's EV / EBITDA changed year-over-year?
Lifevantage Corporation's EV / EBITDA decreased by 47.3% year-over-year, from 10.7× to 5.6×.
What is the long-term trend for Lifevantage Corporation's EV / EBITDA?
Over 4 years (2021 to 2025), Lifevantage Corporation's EV / EBITDA has grown at a 21.3% compound annual growth rate (CAGR), from 4.4× to 9.5×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.